Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Complement in neurobiology.
Features of Human CD3+CD20+ T Cells.
Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury.
[MR imaging of multiple sclerosis].
Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection.
Altered microglia morphology and higher resilience to stress-induced depression-like behavior in CX3CR1-deficient mice.
Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant.
Should MRI be the primary endpoint of phase 3 trials in multiple sclerosis?
Patterns and predictors of naturally occurring change in depressive symptoms over a 30-month period in multiple sclerosis.
Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica.
Neurology in the developing world.
Aerobic exercise in people with multiple sclerosis: its feasibility and secondary benefits.
Effect of light finger touch in balance control of individuals with multiple sclerosis.
An ex-vivo multiple sclerosis model of inflammatory demyelination using hyperbranched polymer.
Comparison of Vitamin D3 Serum Levels in New Diagnosed Patients with Multiple Sclerosis versus Their Healthy Relatives.
MRI lesions: a surrogate for relapses in multiple sclerosis?
[Thoughts on hot issues of neuromyelitis optica].
[Immunotherapies for multiple sclerosis : Review and update.]
Risk factors for multiple sclerosis and associations with anti-EBV antibody titers.
An initial top-down proteomic analysis of the standard cuprizone mouse model of multiple sclerosis.
Analysis of CH25H in multiple sclerosis and neuromyelitis optica.
High salt drives Th17 responses in experimental autoimmune encephalomyelitis without impacting myeloid dendritic cells.
Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives.
Modulation of oligodendrocyte differentiation and maturation by combined biochemical and mechanical cues.
Targeting FcRn for therapy: From live cell imaging to in vivo studies in mice.

Pages